Engineering Micro–Nanomaterials for Biomedical Translation
Engineered nano–bio interfaces–driven by vertical micro/nanoneedles, nanoparticles, organ‐on‐chip devices, and a diversity of nanosubstrates for mass spectroscopy imaging–are spurring scientific and technological progress, from fundamental to transnational biomedical research. Each class has its own...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2021-09-01
|
| Series: | Advanced NanoBiomed Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/anbr.202100002 |
| _version_ | 1818620306501140480 |
|---|---|
| author | Yaping Chen Maria Alba Terence Tieu Ziqiu Tong Rajpreet Singh Minhas David Rudd Nicolas H. Voelcker Anna Cifuentes-Rius Roey Elnathan |
| author_facet | Yaping Chen Maria Alba Terence Tieu Ziqiu Tong Rajpreet Singh Minhas David Rudd Nicolas H. Voelcker Anna Cifuentes-Rius Roey Elnathan |
| author_sort | Yaping Chen |
| collection | DOAJ |
| description | Engineered nano–bio interfaces–driven by vertical micro/nanoneedles, nanoparticles, organ‐on‐chip devices, and a diversity of nanosubstrates for mass spectroscopy imaging–are spurring scientific and technological progress, from fundamental to transnational biomedical research. Each class has its own characteristic features, which is critical for their translational uptake, but they broadly share the same range of functionality and applicability at the forefront of modern research and medicine. The review provides insights into unique attributes of microneedle technology and its ability for efficient transdermal transport of therapeutic compounds. The uses of nanoneedle technology in precise manipulation of increasingly complex cellular processes at the cell–material interface and their potential for major improvements for many fundamental research applications and ex vivo cell‐based therapies are highlighted. A snapshot in the use of food and drug administration (FDA)‐approved nanoparticle therapeutics and their applications in nanomedicine is provided. The achievements in organ‐on‐chip technology, particularly at the preclinical stage, and its potential to efficiently screen diverse types of therapeutics are covered. The final section is dedicated to the use of nanomaterial‐enhanced mass spectrometry in drug discovery and imaging. Overall, this review aims to highlight those main rules in the design of bio–nano interfaces that have successfully achieved translation into the market. |
| first_indexed | 2024-12-16T17:51:17Z |
| format | Article |
| id | doaj.art-a1df1369fdc345079c45b725fa602b15 |
| institution | Directory Open Access Journal |
| issn | 2699-9307 |
| language | English |
| last_indexed | 2024-12-16T17:51:17Z |
| publishDate | 2021-09-01 |
| publisher | Wiley-VCH |
| record_format | Article |
| series | Advanced NanoBiomed Research |
| spelling | doaj.art-a1df1369fdc345079c45b725fa602b152022-12-21T22:22:18ZengWiley-VCHAdvanced NanoBiomed Research2699-93072021-09-0119n/an/a10.1002/anbr.202100002Engineering Micro–Nanomaterials for Biomedical TranslationYaping Chen0Maria Alba1Terence Tieu2Ziqiu Tong3Rajpreet Singh Minhas4David Rudd5Nicolas H. Voelcker6Anna Cifuentes-Rius7Roey Elnathan8Monash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaMonash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville VIC 3052 AustraliaEngineered nano–bio interfaces–driven by vertical micro/nanoneedles, nanoparticles, organ‐on‐chip devices, and a diversity of nanosubstrates for mass spectroscopy imaging–are spurring scientific and technological progress, from fundamental to transnational biomedical research. Each class has its own characteristic features, which is critical for their translational uptake, but they broadly share the same range of functionality and applicability at the forefront of modern research and medicine. The review provides insights into unique attributes of microneedle technology and its ability for efficient transdermal transport of therapeutic compounds. The uses of nanoneedle technology in precise manipulation of increasingly complex cellular processes at the cell–material interface and their potential for major improvements for many fundamental research applications and ex vivo cell‐based therapies are highlighted. A snapshot in the use of food and drug administration (FDA)‐approved nanoparticle therapeutics and their applications in nanomedicine is provided. The achievements in organ‐on‐chip technology, particularly at the preclinical stage, and its potential to efficiently screen diverse types of therapeutics are covered. The final section is dedicated to the use of nanomaterial‐enhanced mass spectrometry in drug discovery and imaging. Overall, this review aims to highlight those main rules in the design of bio–nano interfaces that have successfully achieved translation into the market.https://doi.org/10.1002/anbr.202100002mass spectrometrynanobiotechnologiesnanoparticlesorgan-on-chip platformsvertical nanostructures |
| spellingShingle | Yaping Chen Maria Alba Terence Tieu Ziqiu Tong Rajpreet Singh Minhas David Rudd Nicolas H. Voelcker Anna Cifuentes-Rius Roey Elnathan Engineering Micro–Nanomaterials for Biomedical Translation Advanced NanoBiomed Research mass spectrometry nanobiotechnologies nanoparticles organ-on-chip platforms vertical nanostructures |
| title | Engineering Micro–Nanomaterials for Biomedical Translation |
| title_full | Engineering Micro–Nanomaterials for Biomedical Translation |
| title_fullStr | Engineering Micro–Nanomaterials for Biomedical Translation |
| title_full_unstemmed | Engineering Micro–Nanomaterials for Biomedical Translation |
| title_short | Engineering Micro–Nanomaterials for Biomedical Translation |
| title_sort | engineering micro nanomaterials for biomedical translation |
| topic | mass spectrometry nanobiotechnologies nanoparticles organ-on-chip platforms vertical nanostructures |
| url | https://doi.org/10.1002/anbr.202100002 |
| work_keys_str_mv | AT yapingchen engineeringmicronanomaterialsforbiomedicaltranslation AT mariaalba engineeringmicronanomaterialsforbiomedicaltranslation AT terencetieu engineeringmicronanomaterialsforbiomedicaltranslation AT ziqiutong engineeringmicronanomaterialsforbiomedicaltranslation AT rajpreetsinghminhas engineeringmicronanomaterialsforbiomedicaltranslation AT davidrudd engineeringmicronanomaterialsforbiomedicaltranslation AT nicolashvoelcker engineeringmicronanomaterialsforbiomedicaltranslation AT annacifuentesrius engineeringmicronanomaterialsforbiomedicaltranslation AT roeyelnathan engineeringmicronanomaterialsforbiomedicaltranslation |